Overview Fundamentals API Earnings EOD API Sample Code Pricing

Tempest Therapeutics Inc (TPST NASDAQ) stock market data APIs

$1.33 -0.12(-8.3%) as of September 13, 2024
Price chart is built with Anychart

Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.

Tempest Therapeutics Inc Financial Data Overview

1.45
1.33
-
1.46
1.33
0.17-9.77
36 551 K
25 208 K
0
-0.42
-2.884
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TPST',
Type: 'Common Stock',
Name: 'Tempest Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG002NDK339',
ISIN: NULL,
CUSIP: NULL,
CIK: '1544227',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2012-11-12',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Tempest Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -31 246 000
  • Earnings Per Share -1.6
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Tempest Therapeutics Inc Earnings via APIs

  • Latest Release 2024-08-08
  • EPS/Forecast -0.4

Get Tempest Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com